Lance Alstodt - BioRestorative Therapies President Board

BRTX Stock  USD 1.53  0.05  3.38%   

President

Lance Alstodt is President Board of BioRestorative Therapies
Age 53
Address 40 Marcus Drive, Melville, NY, United States, 11747
Phone631 760 8100
Webhttps://www.biorestorative.com

Lance Alstodt Latest Insider Activity

Tracking and analyzing the buying and selling activities of Lance Alstodt against BioRestorative Therapies stock is an integral part of due diligence when investing in BioRestorative Therapies. Lance Alstodt insider activity provides valuable insight into whether BioRestorative Therapies is net buyers or sellers over its current business cycle. Note, BioRestorative Therapies insiders must abide by specific rules, including filing SEC forms every time they buy or sell BioRestorative Therapies'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

BioRestorative Therapies Management Efficiency

The company has return on total asset (ROA) of (0.5324) % which means that it has lost $0.5324 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1712) %, meaning that it created substantial loss on money invested by shareholders. BioRestorative Therapies' management efficiency ratios could be used to measure how well BioRestorative Therapies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.92 in 2024. Return On Capital Employed is likely to rise to -1.45 in 2024. At this time, BioRestorative Therapies' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 320.5 K in 2024, despite the fact that Non Currrent Assets Other are likely to grow to (842.6 K).
BioRestorative Therapies currently holds 162.32 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. BioRestorative Therapies has a current ratio of 28.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about BioRestorative Therapies' use of debt, we should always consider it together with its cash and equity.
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York. Biorestorative Therapies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. BioRestorative Therapies (BRTX) is traded on NASDAQ Exchange in USA. It is located in 40 Marcus Drive, Melville, NY, United States, 11747 and employs 11 people. BioRestorative Therapies is listed under Biotechnology category by Fama And French industry classification.

Management Performance

BioRestorative Therapies Leadership Team

Elected by the shareholders, the BioRestorative Therapies' board of directors comprises two types of representatives: BioRestorative Therapies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioRestorative. The board's role is to monitor BioRestorative Therapies' management team and ensure that shareholders' interests are well served. BioRestorative Therapies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioRestorative Therapies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Francisco Silva, VP Scientist
Robert Paccasassi, Vice Compliance
Stephen Kilmer, Investor Officer
Wayne MD, Clinical Board
Robert Kristal, Chief Officer
Lance Alstodt, President Board

BioRestorative Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioRestorative Therapies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.